Publication | Closed Access

Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway

InflammationNuclear FactorAnti-inflammatoryCholesterol-induced Hepatic InflammationMedicineLiver PhysiologyMatrix Metalloproteinases-2ImmunologyChronic InflammationHepatotoxicityPharmacologyInflammatory DiseaseDrug-induced Liver InjuryOxidative Stress